| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,107 | 21,635 | 21,815 | 20,398 | | Cost of Revenue | 13,398 | 14,199 | 13,110 | 13,065 | | | Gross Profit | 5,709 | 7,436 | 8,705 | 7,333 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,752 | 3,063 | 3,607 | 4,353 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,957 | 4,373 | 5,098 | 2,980 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 6 | 13 | 95 | | Earnings Before Interest And Taxes | 1,963 | 4,379 | 5,111 | 3,075 | | Interest Expense |
-
|
-
|
-
| 56 | | Income Before Tax | 1,963 | 4,379 | 5,111 | 3,019 | | Income Tax Expense | 667 | 1,175 | 1,530 | (2,588) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,296 | 3,204 | 3,581 | 5,607 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,296 | 3,204 | 3,581 | 5,607 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,296 | $3,204 | $3,581 | $5,607 |
|
0.51% Nasdaq 
Income Statement
